Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Epiphron Capital
AddedFeb 15, 2024
UpdatedJun 28, 2026
Epiphron Capital

Epiphron Capital

Operating

Epiphron Capital: A dedicated investment firm specializing in healthcare funds.

Location
North Bergen, NJ, US
Firm
Compare
Portfolio
Employees
Website

Epiphron Capital is a dedicated investment firm specializing in healthcare funds. The firm typically invests in Series B rounds, focusing on companies within the healthcare sector. Their investment strategy centers on identifying and supporting innovative healthcare solutions that have the potential to make significant impacts in the industry.

Notable portfolio companies include Clarapath, which has raised $16 million with Epiphron's support. The firm's key partners and decision-makers bring extensive experience from leading healthcare and investment institutions, providing strategic guidance and industry insights. Epiphron Capital offers unique value-add services such as operational support, strategic partnerships, and access to a broad network of industry experts to help portfolio companies scale effectively.

Epiphron Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments1
Current Portfolio Count1
Total Portfolio Exits0

Top Investment Stages

Series B1 (100.0%)

Stage Mix

Series B 100%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Clarapath logo

Clarapath

Epiphron Capital - Similar Investment Firms

Aphelion Capital logo

Aphelion Capital

SilverArc Capital logo

SilverArc Capital

Epsilon Health Investors logo

Epsilon Health Investors

epsilonhi.com

Enhanced Healthcare Partners logo

Enhanced Healthcare Partners

Waypoint Capital Partners logo

Waypoint Capital Partners

Pathocapital logo

Pathocapital

HC9 Ventures logo

HC9 Ventures

hc9.vc

Atheneos Capital logo

Atheneos Capital

Kepha Partners logo

Kepha Partners

kephapartners.com

Concord Health Partners logo

Concord Health Partners

concordhp.com

Phalanx Investment Partners logo

Phalanx Investment Partners

Petrichor Healthcare Capital Management logo

Petrichor Healthcare Capital Management

petrichorcap.com

InnovaHealth Partners logo

InnovaHealth Partners

Regal Healthcare Capital Partners logo

Regal Healthcare Capital Partners

regalhcp.com

HealthTrend Capital logo

HealthTrend Capital

healthtrendcap.com

Epiphron Capital - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified